Product NDC 49281-0590

3 active presentations under this Product NDC family.

Review package-specific NDC rows, compare configurations, and request pricing through the RFQ workflow.

Need a Product Not Listed?

Submit a custom quote request for unlisted NDCs, item codes, or alternate product presentations.

Drug Catalog Search | Request a Custom Quote

Family context

Product NDC 49281-0590 groups closely related presentations under the same catalog family, giving healthcare teams a clearer path for comparing packaging and alternate exact NDC rows before an RFQ is submitted.

  • Family size: 3 active presentations.
  • Generic family: NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN.
  • Primary dosage form: Injection.
  • Common strength: 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL.

What changes inside this family

Use the family page to compare formats, then click into the exact NDC page that matches the package your team needs.

  • Manufacturers shown: Sanofi Pasteur Inc..
  • Dosage forms shown: Injection.
  • Package quantities: 1 Vial, Single-Dose, 5 Vial, Single-Dose, and 10 Vial, Single-Dose.

Manufacturer pathways

Official family references

Use official family-level references to verify labeling context while comparing the child NDC presentations shown on this page.

Showing page 1 of 1
NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL Injection 0.5 mL (MenQuadfi)49281-0590-0110 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mLInjection1 Vial, Single-Dose
NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL Injection 0.5 mL (MenQuadfi)49281-0590-0510 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mLInjection5 Vial, Single-Dose
NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL Injection 0.5 mL (MenQuadfi)49281-0590-1010 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mLInjection10 Vial, Single-Dose

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.